DNA X公司2026年季度报告

FORM 10-Q Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes☐No☒ On May 14, 2026, there were 1,488,268 shares of the registrant’s common stock, par value $0.001, outstanding. 223,201 of suchshares are redeemable. Table of Contents CAUTIONARY NOTE ABOUT FORWARD-LOOKING STATEMENTS This Quarterly Report on Form 10-Q contains statements that we believe are “forward-looking statements” within the meaning of thePrivate Securities Litigation Reform Act of 1995. Those forward-looking statements are intended to enjoy the protection of the safeharbor for forward-looking statements provided by that act as well as protections afforded by other federal securities laws. Generally,words such as “achieve,” “aim,” “ambitions,” “anticipate,” “believe,” “committed,” “continue,” “could,” “designed,” “estimate,”“expect,”“forecast,”“future,”“goals,”“grow,”“guidance,”“intend,”“likely,”“may,”“milestone,”“objective,”“on track,”“opportunity,” “outlook,” “pending,” “plan,” “position,” “possible,” “potential,” “predict,” “progress,” “roadmap,” “seek,” “should,” (i) outcome of, and future effect on our financial condition and results of operations of, certain litigations and otherproceedings to which we are a party;(ii)Part I, Item 2. “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” includingthe statements with regard to the future changes to our business and our expectations regarding our strategy and new Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those anticipatedby these forward-looking statements. These risks and uncertainties include, but are not limited to, the following: ●the availability of cash on hand and other sources of liquidity to fund our operations and grow our business;●our ability to compete effectively depends on multiple factors and we may not be able to continue to developsolutions to address user needs effectively;●we may not be able to continue to develop solutions to address user needs effectively, including features for traderson our cryptocurrency trading platform;●cryptocurrency values have been volatile and may cause a decrease in trading activity on our cryptocurrency tradingplatform;●the financial and operational projections that we may provide from time to time are subject to inherent risks;●our ability to incorporate emerging technologies into our trading software given the lengthy development cycle; We urge investors to consider all of the risks, uncertainties, and other factors disclosed in these filings carefully in evaluating theforward-looking statements contained in this report. We cannot assure you that the results or developments anticipated by us andreflected or implied by any forward-looking statement contained in this report will be realized or, even if substantially realized, thatthose results or developments will result in the forecasted or expected consequences for us or affect us, our operations or financialperformance as we forecasted or expected. As a result of the matters discussed above and other matters, including changes in facts, As used herein, “DNA X,” the “Company,” “we,” “us,” “our,” and similar terms include DNA X, Inc. and its subsidiaries, unless thecontext indicates otherwise. NOTE 1 — The Company and Its Significant Accounting Policies Description of Business—DNA X, Inc. (“the Company”) was incorporated in the state of Delaware on August 5, 1999 under the nameSonim Technologies Inc., and is headquartered in San Diego, California. Effective January 23, 2026, the Company changed its name toDNA X, Inc. The Company operates an AI and crypto trading platform that operates on the internet and is designed to harnessadvanced AI and machine learning technologies to automate intelligent trading strategies, enabling clients to capitalize on data-driven The Company generates revenue from trading commissions that are based on the value of the trades that customers execute on theCompany’s DNA X trading website. Customers are individual investors from around the world. DNA X has positioned itself as a lowprice trading platform that allows traders to implement strategies to take advantage of fluctuations in relative values of cryptocurrencypairs. The platform allows investors to set up automated trading strategies, to monitor other trader’s trading strategies in real time, andto simulate trades without any cost. DNA X has been operating since November and has grown through word-of-mouth and social Liquidity and Ability to Continue as a Going Concern—The Company’s consolidated financial statements account for thecontinuation of its business as a going concern. The Company is subject to the risks and uncertainties associated with operating an AIand crypto trading platform including the ability to attract new customers and to keep existing customers from moving their businessto other competitors. On M